Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells

[21] Geles KG(2010)High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model Cancer Res 70 9444-567

[22] Grindley JC(2008)Tumor-initiating function of nucleostemin-enriched mammary tumor cells Cancer Metastasis Rev 27 459-1215

[23] Dirks PB(2010)Cancer stem cells: markers or biomarkers? Breast Cancer 17 80-163

[24] Phillips TM(2007)Breast cancer stem cells Cell Stem Cell 1 555-666

[25] McBride WH(2005)ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Cycle 4 1201-338

[26] Pajonk F(2008)Molecular targets and anticancer potential of indole-3- carbinol and its derivatives Cancer Letts 262 153-607

[27] O'Brien CS(2010)Indole-3-carbinol as a chemopreventive and anti-cancer agent Curr Drug Targets 11 652-1947

[28] Howell SJ(2008)Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy Cancer Letts 269 326-2455S

[29] Farnie G(2009)Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs Cancer Treat Rev 35 597-868

[30] Clarke RB(2009)Harnessing the fruits of nature for the development of multi- targeted cancer therapeutics Mol Endocrinol 23 1940-19755

[21] Geles KG(2010)High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model Cancer Res 70 9444-567

[22] Grindley JC(2008)Tumor-initiating function of nucleostemin-enriched mammary tumor cells Cancer Metastasis Rev 27 459-1215

[23] Dirks PB(2010)Cancer stem cells: markers or biomarkers? Breast Cancer 17 80-163

[24] Phillips TM(2007)Breast cancer stem cells Cell Stem Cell 1 555-666

[25] McBride WH(2005)ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Cycle 4 1201-338

[26] Pajonk F(2008)Molecular targets and anticancer potential of indole-3- carbinol and its derivatives Cancer Letts 262 153-607

[27] O'Brien CS(2010)Indole-3-carbinol as a chemopreventive and anti-cancer agent Curr Drug Targets 11 652-1947

[28] Howell SJ(2008)Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy Cancer Letts 269 326-2455S

[29] Farnie G(2009)Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs Cancer Treat Rev 35 597-868

[30] Clarke RB(2009)Harnessing the fruits of nature for the development of multi- targeted cancer therapeutics Mol Endocrinol 23 1940-19755